Compare Novartis AG (NVS) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Unilever plc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Unilever plc trades at $62.18 (market cap $131.86B). The key difference: Novartis AG is far larger — about 2.2× Unilever plc's market cap, and Unilever plc pays the higher dividend (3.68%). Which is the better fit depends on your goals.
| NVS | UL | |
|---|---|---|
Market Cap | $290.25B | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $168.62 | $74.59 |
52-Week Low | $113.50 | $55.05 |
Enterprise Value | $330.27B | $157.31B |
Dividend Yield | 3.17% | 3.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
